Видео ютуба по тегу Hope Rugo

Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras
Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras
Expanding Treatment Options for Breast Cancer: ADCs and Oral SERDs
Expanding Treatment Options for Breast Cancer: ADCs and Oral SERDs
Клинические данные: оптимизация дозировки рибоциклиба, абемациклиба и палбоциклиба.
Клинические данные: оптимизация дозировки рибоциклиба, абемациклиба и палбоциклиба.
Ингибиторы CDK4/6 при метастатическом HR+ раке молочной железы: круглый стол экспертов.
Ингибиторы CDK4/6 при метастатическом HR+ раке молочной железы: круглый стол экспертов.
Основные моменты конференции SABCS 2025 по метастатическому HR+ раку молочной железы: д-р Хоуп Руго
Основные моменты конференции SABCS 2025 по метастатическому HR+ раку молочной железы: д-р Хоуп Руго
SABCS Snippets: Эндокринная терапия
SABCS Snippets: Эндокринная терапия
ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of ...
ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of ...
ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of ...
ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of ...
Обзор и обновление Napa 2025: новости по раку молочной железы от ASCO с доктором Хоуп Руго, Город...
Обзор и обновление Napa 2025: новости по раку молочной железы от ASCO с доктором Хоуп Руго, Город...
Role of Oral SERDs in the Care of Patients with ER-Positive Metastatic Breast Cancer
Role of Oral SERDs in the Care of Patients with ER-Positive Metastatic Breast Cancer
The Evolving Landscape of Bispecific Antibodies in Hematologic and Solid Tumors
The Evolving Landscape of Bispecific Antibodies in Hematologic and Solid Tumors
Yours Truly: Dr. Hope S. Rugo | Pursuing Cancer Cures at the Speed of Life
Yours Truly: Dr. Hope S. Rugo | Pursuing Cancer Cures at the Speed of Life
Identifying Risk Factors for ILD Recurrence and Severity After T-DXd Retreatment
Identifying Risk Factors for ILD Recurrence and Severity After T-DXd Retreatment
When to stop T-DXd? T-DXd Holidays
When to stop T-DXd? T-DXd Holidays
T-DXd Retreatment After Grade 1 ILD: Safety Insights From a Pooled Analysis
T-DXd Retreatment After Grade 1 ILD: Safety Insights From a Pooled Analysis
Optimizing PI3Kα Testing and Therapy in HR+/HER2- Advanced Breast Cancer Care
Optimizing PI3Kα Testing and Therapy in HR+/HER2- Advanced Breast Cancer Care
Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Op...
Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Op...
Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Op...
Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Op...
Highlighting Breast Cancer Advances at IBC East
Highlighting Breast Cancer Advances at IBC East
Oncology and Suffering: Strategies on Coping with Grief for Health Care Professionals
Oncology and Suffering: Strategies on Coping with Grief for Health Care Professionals
Optimizing the Management of Endocrine-Resistant HR-Positive Metastatic Breast Cancer: Video Lecture
Optimizing the Management of Endocrine-Resistant HR-Positive Metastatic Breast Cancer: Video Lecture
Optimizing the Management of Endocrine-Resistant HR-Positive Metastatic Breast Cancer
Optimizing the Management of Endocrine-Resistant HR-Positive Metastatic Breast Cancer
Current and Future Clinical Care of Patients with Metastatic Breast Cancer
Current and Future Clinical Care of Patients with Metastatic Breast Cancer
Metastatic Breast Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
Metastatic Breast Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
Integrating Metastatic Triple-Negative Breast Cancer NCCN Guidelines Into Clinical Practice
Integrating Metastatic Triple-Negative Breast Cancer NCCN Guidelines Into Clinical Practice